Skip to main content

Overview of Affordable Upfront Point-of-Care Testing for Cancer Detection

  • Chapter
  • First Online:
Nanobiosensors for point-of-care medical diagnostics

Abstract

Point-of-care (POC) examination secures quick assessment of analytes in patients’ samples promoting a more reliable disease diagnosis, management, and control. It also allows for fast clinical decisions, because the disease might be identified in the early stages to enhance the health issues, and the patient might begin the medication on time. The available literature showed that several possible POC tools have been fabricated for next-generation POC diagnosis. Biosensors are extremely significant elements of POC tools directly accountable for the bio-analytical performance of laboratory experiments. The nano-biosensor is a category of biosensors and has played an essential role as manageable or moveable devices in the quick analysis of disease in clinical practice such as POC devices. Mostly, nano-biosensors have been developed with the recognition of a biological molecule fixed upon the signal transducer surface. The heterogeneous reaction has occurred between the bio-recognition molecule and the analyte of the biological samples. Therefore, the performance of nano-biosensors depends on the designing of the bio-sensing interface such as biomaterials, immobilized molecules, reacting agents, etc. Nano-biosensors might help in the rapid diagnosis with valuable cost and are easy to use with very high sensitivity and specificity. In this chapter, we have explored nanotechnology in the fabrication of nano-biosensors with prevails aims for POC diagnosis of various types of cancers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Abdulhalim I et al (2008) Surface plasmon resonance for biosensing: a mini-review. Electromagnetics 28(3):214–242

    Article  Google Scholar 

  • Alegre MM et al (2014) Serum detection of thymidine kinase 1 as a means of early detection of lung cancer. Anticancer Res 34(5):2145

    Google Scholar 

  • American Cancer Society (2015) Cancer facts & figures. www.cancer.org/acs/groups/content/@editorial/documents/document/acspc-044552.pdf

  • American Cancer Society (2016). https://oralcancerfoundation.org/wp-content/uploads/2016/03/Us_Cancer_Facts.pdf

  • American Cancer Society (n.d.) Kidney cancer. www.cancer.org/cancer/kidneycancer

  • Bray F et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424

    Article  Google Scholar 

  • Burne P, Mitchell S, Smith BR (2005) Point-of-care assays for autoantibodies to thyroid peroxidase and to thyroglobulin. Thyroid 15(9):1005–1010

    Article  CAS  Google Scholar 

  • CDC (n.d.). https://www.cdc.gov/cancer/kinds.htm

  • Chakravarthy K et al (2021) Review of the current state of urine drug testing in chronic pain: still effective as a clinical tool and curbing abuse, or an arcane test? Curr Pain Headache Rep 25:12. https://doi.org/10.1007/s11916-020-00918-z

    Article  Google Scholar 

  • Chang Y-F et al (2013) The utility of a high-throughput scanning biosensor in the detection of the pancreatic cancer marker ULBP2. Biosens Bioelectron 41:232–237

    Article  CAS  Google Scholar 

  • Chen H-C et al (2015) A sensitive and selective magnetic graphene composite-modified polycrystalline-silicon nanowire field-effect transistor for bladder cancer diagnosis. Biosens Bioelectron 66:198–207

    Article  CAS  Google Scholar 

  • Choi S, Chae J (2009) A microfluidic biosensor based on competitive protein adsorption for thyroglobulin detection. Biosens Bioelectron 25(1):118–123

    Article  CAS  Google Scholar 

  • Cytecare (n.d.). https://cytecare.com/blog/statistics-of-breast-cancer/#:~:text=One%20in%20twenty%2Deight%20Indian

  • D’Amico A et al (2008) Identification of melanoma with a gas sensor array. Skin Res Technol 14(2):226–236

    Article  Google Scholar 

  • Damborský P et al (2015) Surface plasmon resonance application in prostate cancer biomarker research. Chem Pap 69(1):143–149

    Article  Google Scholar 

  • Fang X et al (2011) A spectral imaging array biosensor and its application in detection of leukemia cell. Sens Actuators B 156(2):760–764

    Article  CAS  Google Scholar 

  • Feng K-J et al (2006) A nano-porous CeO(2)/Chitosan composite film as the immobilization matrix for colorectal cancer DNA sequence-selective electrochemical biosensor. Talanta 70(3):561–565

    Article  CAS  Google Scholar 

  • Gao X et al (2011) Amperometric immunosensor for carcinoembryonic antigen detection with carbon nanotube-based film decorated with gold nanoclusters. Anal Biochem 414(1):70–76

    Article  CAS  Google Scholar 

  • Gohring JT et al (2010) Detection of HER2 breast cancer biomarker using the opto-fluidic ring resonator biosensor. Sens Actuators B 146(1):226–230

    Article  CAS  Google Scholar 

  • Gubala V et al (2012) Point of care diagnostics: status and future. Anal Chem 84(2):487–515

    Article  CAS  Google Scholar 

  • Gum JR et al (1987) Effects of sodium butyrate on human colonic adenocarcinoma cells. Induction of placental-like alkaline phosphatase. J Biol Chem 262(3):1092–1097

    Article  CAS  Google Scholar 

  • Harris L et al (2007) American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 25(33):5287–5312

    Article  CAS  Google Scholar 

  • Hayes B et al (2018) Developments in point-of-care diagnostic technology for cancer detection. Diagnostics (Basel, Switzerland) 8(2):39

    Google Scholar 

  • Horvath E et al (2009) An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management. J Clin Endocrinol Metab 94(5):1748–1751

    Article  CAS  Google Scholar 

  • Jayasena SD (1999) Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin Chem 45(9):1628–1650

    Article  CAS  Google Scholar 

  • Jokerst JV et al (2009) Nano-bio-chips for high performance multiplexed protein detection: determinations of cancer biomarkers in serum and saliva using quantum dot bioconjugate labels. Biosens Bioelectron 24(12):3622–3629

    Article  CAS  Google Scholar 

  • Jolly P et al (2015) DNA aptamer-based detection of prostate cancer. Chem Pap 69(1):77–89

    Article  CAS  Google Scholar 

  • Kim J-E et al (2004) Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population. J Gastroenterol Hepatol 19(2):182–186

    Article  Google Scholar 

  • Krahn J, Dembinski T (2009) Thyroglobulin and anti-thyroglobulin assays in thyroid cancer monitoring. Clin Biochem 42(4):416–419

    Article  CAS  Google Scholar 

  • Li Z et al (2010) Rapid and sensitive detection of protein biomarker using a portable fluorescence biosensor based on quantum dots and a lateral flow test strip. Anal Chem 82(16):7008–7014

    Article  CAS  Google Scholar 

  • Li CZ et al (2012) Electrochemical sensing of label free DNA hybridization related to breast cancer 1 gene at disposable sensor platforms modified with single walled carbon nanotubes. Electrochim Acta 82:137–142

    Article  CAS  Google Scholar 

  • Lin Y-H et al (2013) A negative-pressure-driven microfluidic chip for the rapid detection of a bladder cancer biomarker in urine using bead-based enzyme-linked immunosorbent assay. Biomicrofluidics 7(2):024103

    Article  Google Scholar 

  • Liu G et al (2009) Aptamer−nanoparticle strip biosensor for sensitive detection of cancer cells. Anal Chem 81(24):10013–10018

    Article  CAS  Google Scholar 

  • Lommen K et al (2020) Biobanking in molecular biomarker research for the early detection of cancer. Cancer 12(4):776

    Article  CAS  Google Scholar 

  • Ludwig JA, Weinstein JN (2005) Biomarkers in cancer staging, prognosis and treatment selection. Nat Rev Cancer 5(11):845–856

    Article  CAS  Google Scholar 

  • Mansor NA et al (2014) Detection of breast cancer 1 (BRCA1) gene using an electrochemical DNA biosensor based on immobilized ZnO nanowires. Open J Appl Biosens 03(02):9

    Article  Google Scholar 

  • Mansur AAP et al (2014) Fluorescent nanohybrids based on quantum dot–chitosan–antibody as potential cancer biomarkers. ACS Appl Mater Interfaces 6(14):11403–11412

    Article  CAS  Google Scholar 

  • Matsumura LC et al (2012) The effect of content-focused coaching on the quality of classroom text discussions. J Teacher Educ 63:214–228

    Article  Google Scholar 

  • Matzke LA, Watson PH (2020) Biobanking for cancer biomarker research: issues and solutions. Biomarker Insights 15:1177271920965522. https://doi.org/10.1177/1177271920965522

    Article  Google Scholar 

  • Min K-W (2005) Stromal elements for tumor diagnosis: a brief review of diagnostic electron microscopic features. Ultrastruct Pathol 29(3–4):305–318

    Article  Google Scholar 

  • Mohd Azmi MA et al (2014) Highly sensitive covalently functionalised integrated silicon nanowire biosensor devices for detection of cancer risk biomarker. Biosens Bioelectron 52:216–224

    Article  CAS  Google Scholar 

  • Mossberg M et al (2014) A direct electrochemical detection method of melanoma based on melanoma biomarker. Electroanalysis 26(8):1671–1675

    Article  CAS  Google Scholar 

  • National Cancer Institute (n.d.-a). https://www.cancer.gov/types

  • National Cancer Institute (n.d.-b). https://www.cancer.gov/types/common-cancers

  • Nayak S et al (2017) Point-of-care diagnostics: recent developments in a connected age. Anal Chem 89(1):102–123

    Article  CAS  Google Scholar 

  • NIH (n.d.). https://www.nih.gov/about-nih/what-we-do/nih-almanac/national-cancer-institute-nci

  • Nikolaou M et al (2018) The challenge of drug resistance in cancer treatment: a current overview. Clin Exp Metastasis 35(4):309–318

    Article  CAS  Google Scholar 

  • Omidfar K et al (2020) Point-of-care biosensors in medicine: a brief overview of our achievements in this field based on the conducted research in EMRI (endocrinology and metabolism research Institute of Tehran University of medical sciences) over the past fourteen years. J Diabetes Metab Disord. https://doi.org/10.1007/s40200-020-00668-0

  • Rasheed PA, Sandhyarani N (2014) Femtomolar level detection of BRCA1 gene using a gold nanoparticle labeled sandwich type DNA sensor. Colloids Surf B Biointerfaces 117:7–13

    Article  Google Scholar 

  • Rawla P et al (2019) Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Przeglad Gastroenterologiczny 14(2):89–103

    CAS  Google Scholar 

  • Ronkainen NJ, Okon SL (2014) Nanomaterial-based electrochemical immunosensors for clinically significant biomarkers. Materials (Basel, Switzerland) 7(6):4669–4709

    Article  Google Scholar 

  • Sachdeva S et al (2020) Microfluidic point-of-care testing: commercial landscape and future directions. Front Bioeng Biotechnol 8:602659. https://doi.org/10.3389/fbioe.2020.602659

    Article  Google Scholar 

  • Shan W et al (2014) An aptamer-based quartz crystal microbalance biosensor for sensitive and selective detection of leukemia cells using silver-enhanced gold nanoparticle label. Talanta 126:130–135

    Article  CAS  Google Scholar 

  • Silveira-Moriyama L et al (2008) Hyposmia in G2019S LRRK2-related parkinsonism. Clin Pathol Data 71(13):1021–1026

    CAS  Google Scholar 

  • Simon E (2010) Biological and chemical sensors for cancer diagnosis. Meas Sci Technol 21(11):112002

    Article  Google Scholar 

  • Singamaneni, L. H. C. M. J. K. E. S. (2012) Label-free detection of renal cancer. USA

    Google Scholar 

  • Slovis NM et al (2020) Point-of-care diagnostics in equine practice. Vet Clin North Am Equine Pract 36(1):161–171

    Article  Google Scholar 

  • Song Y et al (2014) Point-of-care technologies for molecular diagnostics using a drop of blood. Trends Biotechnol 32(3):132–139

    Article  CAS  Google Scholar 

  • Soper SA et al (2006) Point-of-care biosensor systems for cancer diagnostics/prognostics. Biosens Bioelectron 21(10):1932–1942

    Article  CAS  Google Scholar 

  • Syedmoradi L et al (2019) A review on nanomaterial-based field effect transistor technology for biomarker detection. Microchim Acta 186:739

    Article  CAS  Google Scholar 

  • Tao L et al (2012) Anti-epithelial cell adhesion molecule monoclonal antibody conjugated fluorescent nanoparticle biosensor for sensitive detection of colon cancer cells. Biosens Bioelectron 35(1):186–192

    Article  CAS  Google Scholar 

  • Tian L et al (2012) Bioplasmonic paper as a platform for detection of kidney cancer biomarkers. Anal Chem 84(22):9928–9934

    Article  CAS  Google Scholar 

  • Tie J et al (2015) Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer. Ann Oncol 26(8):1715–1722

    Article  CAS  Google Scholar 

  • Tie J et al (2016) Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer. Sci Transl Med 8(346):346ra392

    Article  Google Scholar 

  • Tothill IE (2009) Biosensors for cancer markers diagnosis. Semin Cell Dev Biol 20(1):55–62

    Article  CAS  Google Scholar 

  • Urology Care Foundation (n.d.). https://www.urologyhealth.org/healthy-living/urologyhealth-extra/magazine-archives/spring-2017/understanding-kidney-cancer#:~:text=Kidney%20cancer%2C%20also%20known%20as,rid%20the%20body%20of%20waste

  • Vernick S et al (2011) Electrochemical biosensing for direct biopsy slices screening for colorectal cancer detection. J Electrochem Soc 158(1):P1–P4

    Article  CAS  Google Scholar 

  • Wan Y et al (2011) Carbon nanotube-based ultrasensitive multiplexing electrochemical immunosensor for cancer biomarkers. Biosens Bioelectron 30(1):93–99

    Article  CAS  Google Scholar 

  • Wang Z et al (2008) A sequence-selective electrochemical DNA biosensor based on HRP-labeled probe for colorectal cancer DNA detection. Anal Lett 41(1):24–35

    Article  Google Scholar 

  • Wu M-S et al (2012) Sensitive electrochemiluminescence detection of c-Myc mRNA in breast cancer cells on a wireless bipolar electrode. Anal Chem 84(12):5407–5414

    Article  CAS  Google Scholar 

  • Yamada KM et al (2019) Extracellular matrix dynamics in cell migration, invasion and tissue morphogenesis. Int J Exp Pathol 100(3):144–152

    Article  CAS  Google Scholar 

  • Yang J et al (2019) Detection platforms for point-of-care testing based on colorimetric, luminescent and magnetic assays: a review. Talanta 202:96–110

    Article  CAS  Google Scholar 

  • Zhang B et al (2014a) Proteogenomic characterization of human colon and rectal cancer. Nature 513(7518):382–387

    Article  CAS  Google Scholar 

  • Zhang C et al (2014b) Electrochemical detection of specific DNA sequences related to bladder cancer on CdTe quantum dots modified glassy carbon electrode. J Electroanal Chem 735:115–122

    Article  CAS  Google Scholar 

  • Zhang Q et al (2014c) Amperometric carbohydrate antigen 19-9 immunosensor based on three dimensional ordered macroporous magnetic Au film coupling direct electrochemistry of horseradish peroxidase. Anal Chim Acta 815:42–50

    Article  CAS  Google Scholar 

  • Zwick E et al (2001) Receptor tyrosine kinase signalling as a target for cancer intervention strategies. Endocr Relat Cancer 8(3):161–173

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kumar, S. et al. (2022). Overview of Affordable Upfront Point-of-Care Testing for Cancer Detection. In: Gogoi, M., Patra, S., Kundu, D. (eds) Nanobiosensors for point-of-care medical diagnostics . Springer, Singapore. https://doi.org/10.1007/978-981-19-5141-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-981-19-5141-1_6

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-19-5140-4

  • Online ISBN: 978-981-19-5141-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics